BWXT’s BANR Microreactor Chosen for Canadian Transportable Nuclear Power Plant Project
(TORONTO – Oct. 5, 2026) BWX Technologies, Inc. (NYSE: BWXT) announced today that Prodigy Clean Energy, Ltd., Pabineau First Nation and Eel River Bar First Nation have selected its BANR microreactor technology for a Transportable Nuclear Power Plant (TNPP) to be located in Belledune, New Brunswick.
BWXT Awarded $189 Million Naval Nuclear Fuel Contract
(LYNCHBURG, Va. – Oct. 1, 2026) BWX Technologies, Inc. (NYSE: BWXT) announced the award of a contract totaling approximately $189 million for the manufacture of naval nuclear reactor fuel.
U.S. Army Chooses BWXT Advanced Nuclear Reactor (BANR) for Janus Program
(LYNCHBURG, Va. – Aug. 3, 2026) BWX Technologies, Inc. (NYSE: BWXT) announced today it has entered into a definitive agreement to sell its medical business to Nordic Capital, an experienced healthcare investor with broad expertise and a deep understanding of the radiopharmaceutical industry and its value chain. The transaction, valued at up to $800 million, includes BWXT Medical and Kinectrics’ stable medical isotopes business.
BWXT Names Suzanne Maddux SVP of Operations as Company Scales for Long-term Growth
(LYNCHBURG, Va. – Aug. 20, 2026) BWX Technologies, Inc. (BWXT) announced today that Suzanne Maddux has been named senior vice president, operations, reporting directly to President and Chief Executive Officer Rex Geveden. This newly created position will support the company’s continued growth in nuclear national security and commercial nuclear power markets.
BWX Technologies Reports Second Quarter 2026 Results
LYNCHBURG, Va. -BWX Technologies, Inc. (NYSE: BWXT) (“BWXT”, “we”, “us” or the “Company”) reported second quarter 2026 results. A reconciliation of non-GAAP results is detailed in Exhibit 1.
BWXT Selling Medical Business to Nordic Capital in Transaction Valued at up to $800 Million
(LYNCHBURG, Va. – Aug. 3, 2026) BWX Technologies, Inc. (NYSE: BWXT) announced today it has entered into a definitive agreement to sell its medical business to Nordic Capital, an experienced healthcare investor with broad expertise and a deep understanding of the radiopharmaceutical industry and its value chain. The transaction, valued at up to $800 million, includes BWXT Medical and Kinectrics’ stable medical isotopes business.
BWXT Completes Acquisition of Precision Components Group, Expanding U.S. Nuclear Manufacturing Capacity
(LYNCHBURG, Va. – July 6, 2026) – BWX Technologies, Inc. (NYSE: BWXT) announced today that it has successfully completed its previously announced acquisition of Precision Components Group, LLC (PCG), including its subsidiaries Precision Custom Components (PCC) and DC Fabricators (DCF). PCG is a U.S. manufacturer of complex, heavy-walled and heat-transfer components. The acquisition expands BWXT’s heavy-manufacturing footprint and enhances the company’s ability to deliver U.S.-made nuclear components for the commercial sector.
BWXT Manufactures TRISO Fuel Enabling First New Reactor Criticality Under DOE Program
(LYNCHBURG, Va. – Feb. 5, 2026) Last May, the Administration issued a series of Executive Orders aimed at strengthening and, in some cases, jump-starting the commercial and national security nuclear industries. Since then, BWX Technologies, Inc. (NYSE: BWXT) has played a vital role in delivering on the goals of those executive orders, including Executive Order 14301, which directed the U.S. Department of Energy (DOE) to establish a reactor pilot program to test three advanced reactor designs by July 4.
BWXT Commemorates America’s 250th Anniversary by Honoring a Legacy of Innovation, Service and Freedom
(LYNCHBURG, Va. – June 4, 2026) As the United States marks 250 years since the signing of the Declaration of Independence, BWX Technologies, Inc. (NYSE: BWXT) today announced the start of a month long commemoration celebrating the nation’s Semiquincentennial and the generations of American ingenuity and service that have shaped both the country and the […]
BWXT Announces $1.4 Billion in Contracts for Naval Nuclear Propulsion Program
(LYNCHBURG, Va. – Feb. 5, 2026) Last May, the Administration issued a series of Executive Orders aimed at strengthening and, in some cases, jump-starting the commercial and national security nuclear industries. Since then, BWX Technologies, Inc. (NYSE: BWXT) has played a vital role in delivering on the goals of those executive orders, including Executive Order 14301, which directed the U.S. Department of Energy (DOE) to establish a reactor pilot program to test three advanced reactor designs by July 4.